| 1 |
32802593 | Lithium Intoxication in the Elderly: A Possible Interaction between Azilsartan, Fluvoxamine, and Lithium. | 2020 Apr 1 |
1 |
| 2 |
30620511 | [The Drug Interaction that Psychiatrists Should be Careful about]. | 2016 |
1 |
| 3 |
21277363 | Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes. | 2011 Apr 10 |
1 |
| 4 |
17307149 | 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. | 2007 Apr 6 |
1 |
| 5 |
15199661 | Some aspects of genetic polymorphism in the biotransformation of antidepressants. | 2004 Jan-Feb |
1 |
| 6 |
11876575 | Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. | 2002 Feb |
1 |
| 7 |
12452751 | Fluvoxamine interaction with warfarin. | 2002 Dec |
1 |
| 8 |
11180037 | Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. | 2001 Jan |
3 |
| 9 |
11206048 | Phenytoin intoxication induced by fluvoxamine. | 2001 Feb |
1 |
| 10 |
10192756 | Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes. | 1999 Feb |
1 |
| 11 |
10627170 | CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor. | 1999 Dec |
1 |
| 12 |
9384467 | Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation. | 1997 Nov |
1 |